United States - English - NLM (National Library of Medicine)

remedyrepack inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication ( see warnings) .

United States - English - NLM (National Library of Medicine)

direct_rx - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections conjunctivitis: gram-positive bacteria: gram-negative bacteria: staphylococcus aureus enterobacter cloacae staphylococcus epidermidis haemophilus influenzae streptococcus pneumoniae proteus mirabilis pseudomonas aeruginosa corneal ulcers: gram-positive bacteria: gram-negative bacteria: staphylococcus aureus pseudomonas aeruginosa staphylococcus epidermidis serratia marcescens* streptococcus pneumoniae anaerobic species: propionibacterium acnes ofloxacin ophthal

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: conjunctivitis:        gram-positive bacteria:        gram-negative bacteria:                staphylococcus aureus                enterobacter cloacae                staphylococcus epidermidis                haemophilus influenzae                streptococcus pneumoniae                proteus mirabilis                  pseudomonas aeruginosa corneal ulcers:        gram-positive bacteria:        gram-negative bacteria:                staphylococcus aureus                pseudomonas aeruginosa                staphylococcus epidermidis                serratia marcescens*                streptococcus pneumoniae        anaerobic species:                propionibacterium acnes ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medi

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication ( see warnings) .

United States - English - NLM (National Library of Medicine)

armas pharmaceuticals inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings ).

United States - English - NLM (National Library of Medicine)

proficient rx lp - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin otic solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: otitis externa in adults and pediatric patients, 6 months and older, due to escherichia coli , pseudomonas aeruginosa and staphylococcus aureus. chronic suppurative otitis media in patients 12 years and older with perforated tympanic membranes due to proteus mirabilis , pseudomonas aeruginosa and staphylococcus aureus. acute otitis media in pediatric patients one year and older with tympanostomy tubes due to haemophilus influenzae , moraxella catarrhalis , pseudomonas aeruginosa , staphylococcus aureus and streptococcus pneumoniae . ofloxacin otic solution 0.3% is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

pack pharmaceuticals, llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 3 mg in 1 ml - ciprofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: pseudomonas aeruginosa serratia marcescens * staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae streptococcus (viridans group)* haemophilus influenzae staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.

United States - English - NLM (National Library of Medicine)

henry schein inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 3 mg in 1 ml - ciprofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 3 mg in 1 ml - ciprofloxacin hydrochloride ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: corneal ulcers: pseudomonas aeruginosa serratia marcescens* staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae streptococcus (viridans group)* conjunctivitis: haemophilus influenzae staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin. safety and effectiveness in pediatric patients below the age of 1 year have not been established. although ciprofloxacin and other quinolones cause arthropathy in immature animals after oral administration, topical ocular administration of ciprofloxacin to immature

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 3 mg in 1 ml - ciprofloxacin ophthalmic solution, usp is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.